US Stocks prediction

Behold the immutable form of the SEC filing, dated October 6, 2025, wherein it was disclosed that Beacon, with a discretion as refined as a well-heeled dowager’s selection of a chaise, increased its VXUS stake to 126,033 shares. The total value of this position stood at $9.26 million, a figure that, while eclipsed by the grandeur of their primary assets, nonetheless reflected a prudent diversification of their portfolio-akin to a polite nod extended to a distant cousin at a ball.

Among these seekers, Alphabet, that titanic colossus of Silicon Valley, and D-Wave Quantum, a modest alchemist of qubits, merit the scrutiny of the discerning investor. Their ventures, though divergent, are threads in the same tapestry of ambition, each weaving a narrative of potential and peril.

The cause of this mirth? A confluence of developments that would have made even the most jaded of stockbrokers raise an eyebrow. Chief among them was the company’s elevation of its fiscal 2026 guidance, a move as polished as a butler’s silverware. Revenue, once a nebulous whisper, now hums with the confidence of a man who has just secured a place at the most exclusive club in town. The non-GAAP operating margin, too, received a nudge, its 16.25% figure a testament to the sort of fiscal discipline that would make a Victorian accountant weep with joy.

It began with a map. A map of circuits and circuits. Unico, a company that churns out “next-gen energy whizzpoppers,” and EOS, a firm whispering sweet nothings into battery storage devices (BESS) nodded to each other across a conference table. From this nod sprang a multiyear pact, as binding as a witches’ spell over a cauldron of molten electrons.

It was The Wall Street Journal that, in its quiet way, had breathed life into this story of possible fortune. The newspaper, quoting unnamed “people familiar with the matter” (a phrase that could fill any reader with both hope and skepticism), suggested that Johnson & Johnson, a healthcare behemoth, might be considering acquiring Protagonist. But like the whisper of wind through the trees, the details were absent, leaving one to wonder how much of this is truly rooted in reality, and how much is the mere fantasy of traders hungry for a new story to chase.

Companies involved in artificial intelligence have seen huge stock gains recently. Palantir (PLTR) has increased over 2,000% in three years, while Nvidia (NVDA), a leading AI chipmaker, is up more than 1,300%. Newer cloud companies like Nebius Group (NBIS) and CoreWeave (CRWV) have also experienced significant growth, with their stock prices rising by triple-digit percentages since they went public.

For the third quarter of fiscal 2025, Levi Strauss reported a respectable 6.9% year-over-year increase in revenues, totaling $1.54 billion. The company achieved double-digit growth in Asia, while European revenue growth was somewhat subdued, rising by a mere 3% when adjusted for currency fluctuations. The consensus forecast had pegged revenues at $1.50 billion, a target the company comfortably exceeded.

Kessler Investment Group, located in Indiana (where people still believe stocks are magic), decided to cash out of its Robinhood position during the third quarter. The total value of the 122,349 shares sold? A tidy $11.5 million. This little chunk of change, once a modest 4.7% of Kessler’s assets, is now gone. Perhaps they just couldn’t resist the urge to check out of this rollercoaster ride before someone gets thrown off.

And so, we find ourselves at the crossroads, eager to emulate the titan. How can one, a mere mortal, tap into such unfathomable wisdom? It is, alas, no simple matter. But with the SEC’s sacred quarterly reports, Buffett’s holdings are laid bare, a map to riches-or destruction, depending on how one dares to interpret them. He, too, has his missteps, his faltering moments. Not every acquisition becomes a golden statue. And so, let us examine, with the precision of a surgeon and the heart of a skeptic, two recent acquisitions: one to embrace, and one to shun, as though it were the very embodiment of folly.

It is, undeniably, a contest in which one side is weighted with the full force of corporate might, and the other, a mere fledgling in the corporate wilderness. Nvidia, the undisputed behemoth in the realm of graphics processing units (GPUs), has taken its throne by virtue of nothing more than sheer market dominance. The GPUs it produces have attained the status of legend, and it commands a market share so vast it is all but insurmountable. In contrast, CoreWeave is but a fledgling, a small bird flapping its wings against the suffocating winds of far larger, more entrenched competitors.